Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
News|Articles|December 21, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-01-04-2017
- Volume 12
- Issue 1
Pharma Tech Industries Introduces High-Speed Bottling Line to Missouri Facility
Author(s)Pharmaceutical Technology Editors
Pharma Tech introduced a new high-speed bottling line to its facility in Union, MO.
Advertisement
On Dec. 14, 2016, Pharma Tech Industries introduced a new high-speed bottling line for the production of prescription, over the counter, and nutritional ingestible products at its Union, MO facility. The line includes several units from production equipment manufacturer PneumaticScaleAngelus including unscrambling, filling, checkweighing, metal detection, capping, induction sealing, bundling, and casepacking equipment. The line is capable of filling speeds up to 300 bottles per minute, with a bottle size capacity of five inches in diameter and 10 inches in height.
The new bottling line is housed in a new ISO 8 Class 100,000-controlled environment designed for non-sterile prescription pharmaceutical-grade oral products. The addition is part of Pharma Tech’s recent expansion at its production facility in Union, MO. The multimillion-dollar investment has added approximately 55,000-ft2 of manufacturing space, bringing the facility’s total area to 155,000-ft2. Included in the expansion is another high-speed bottling line, as well as a 20,000-ft2 building housing an analytical/microbial lab, and additional warehousing space.
Source: Pharma Tech Industries
Articles in this issue
almost 10 years ago
New Catalysts Enable Cross-Coupling Reactionsalmost 10 years ago
Outsourced Testing and Manufacturing Support Biosmiliar Projectsalmost 10 years ago
AGC Asahi Glass Acquires CMC Biologicsalmost 10 years ago
Three Novasep Facilities Pass FDA Inspectionalmost 10 years ago
Vetter Begins Manufacturing on Clinical Syringe Filling Linealmost 10 years ago
Aurinia and Lonza Enter into Manufacturing Agreementalmost 10 years ago
Fluor Builds Diabetes API Manufacturing Facility for Novo Nordiskalmost 10 years ago
Lonza to Acquire Capsugelalmost 10 years ago
DuPont Receives Grant from Bill & Melinda Gates FoundationAdvertisement
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Advertisement
Advertisement